Drugs / ARRY-403
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00952198 | Aug 2009 → Aug 2010 | type 2 diabetes mellitus | Array BioPharma | Completed | No outcome recorded |
| Phase 1 | NCT00859755 | Mar → Jul 2009 | type 2 diabetes mellitus | Array BioPharma | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARRY-403 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00859755 ↗ |
| Action | Activate | “glucokinase activator” NCT00859755 ↗ |
| Route | Oral | “ARRY-403, glucokinase activator; oral” NCT00859755 ↗ |